Sanofi's first quarter earnings edges past estimates ahead of CEO change

French drugmaker Sanofi on Thursday reported first-quarter profit and revenue above market expectations, boosted ​by resilient demand for its blockbuster asthma and ‌eczema drug Dupixent.